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Background and aims: Total body iron and high dietary iron intake are risk factors for colorectal cancer.
To date there is no comprehensive characterisation of iron transport proteins in progression to colorectal
carcinoma. In this study, we examined expression of iron import (duodenal cytochrome b (DCYTB),
divalent metal transporter 1 (DMT1), and transferrin receptor 1 (TfR1)) and export (hephaestin (HEPH) and
ferroportin (FPN)) proteins in colorectal carcinoma.
Methods: Perl’s staining was used to examine colonocyte iron content. Real time polymerase chain
reaction (PCR) and western blotting were used to examine mRNA and protein levels of the molecules of
interest in 11 human colorectal cancers. Semiquantitative immunohistochemistry was used to verify protein
levels and information on cellular localisation. The effect of iron loading on E-cadherin expression in
SW480 and Caco-2 cell lines was examined by promoter assays, real time PCR and western blotting.
Results: Perl’s staining showed increased iron in colorectal cancers, and there was a corresponding
overexpression of components of the intracellular iron import machinery (DCYTB, DMT1, and TfR1). The
iron exporter FPN was also overexpressed, but its intracellular location, combined with reduced HEPH
levels, suggests reduced iron efflux in the majority of colorectal cancers examined. Loss of HEPH and FPN
expression was associated with more advanced disease. Iron loading Caco-2 and SW480 cells caused
cellular proliferation and E-cadherin repression.
Conclusions: Progression to colorectal cancer is associated with increased expression in iron import
proteins and a block in iron export due to decreased expression and aberrant localisation of HEPH and
FPN, respectively. This results in increased intracellular iron which may induce proliferation and repress
cell adhesion.
T
here is an emerging body of evidence implicating iron in
the malignant progression of epithelial cancers, including
those of the breast, liver, and colon.1 2 Colorectal cancer
(CRC) is the third most common cancer in the US with over
106 000 new cases and 56 000 estimated deaths from colon
cancer in 2004.3
Evidence of a role for iron in CRC comes from epidemio-
logical, animal, and cellular studies.4–7 Numerous human
epidemiological studies have examined the relationship
between dietary iron, body iron stores, and CRC. One detailed
analysis of 33 epidemiological studies by Nelson revealed
that, among the larger studies, approximately 75% supported
the association of iron with CRC risk.4 A more recent study
suggested that a stronger association of iron and CRC risk is
evident when there is elevated total body iron and a high
dietary iron intake,8 and an important large epidemiological
study from Europe has recently demonstrated a convincing
link between red meat intake and CRC risk.9 Further
epidemiological evidence for a role of iron in CRC study
comes from the observation that patients with HFE muta-
tions have an increased risk of CRC and this is exacerbated by
high dietary iron intake.10 In a normal individual, the amount
of iron required to meet metabolic needs, and hence the
amount absorbed, is usually no more than 10% of the amount
of iron ingested. Consequently, high levels of iron have been
reported within the colonic lumen.10 11 It is also clear from a
host of animal models that when high iron diets are
administered along with a carcinogen, such as dimethylhy-
drazine or cyclic dextran sodium sulphate, colorectal tumour
incidence and tumour multiplicity are increased.6 12 13
Recently, the main proteins involved in the absorption of
non-haem iron have been identified.14 Dietary ferric iron is
reduced to ferrous iron by duodenal cytochrome b (DCYTB),
which is highly expressed on the brush border membrane of
enterocytes.15 Ferrous iron is then transported into the
enterocyte by divalent metal transporter 1 (DMT1, also
known as NRAMP2/DCT1).16 17 Once in the enterocyte, iron
has one of three fates: (i) it can be immediately utilised in the
many cellular processes for which it is essential; (ii) it can be
stored in an inert form bound to ferritin18; or (iii) it may be
exported out of the enterocyte via a pathway which requires
the ferroxidase hephaestin (HEPH),19 20 and the basolateral
iron transporter ferroportin (FPN, also termed IREG1 and
metal transporter protein 1).21 Following export, iron is
transported in serum bound to transferrin (Tf) which
interacts with transferrin receptor 1 (TfR1) on the plasma
membrane of cells which take up iron. The iron/Tf complex is
internalised by receptor mediated endocytosis and iron is
released from transferrin by a mechanism requiring endo-
somal acidification.22
As iron is a prerequisite for cell cycling, it is not surprising
that neoplastic cells and other rapidly dividing cells express
high levels of TfR1, and that iron withdrawal or antisense
TfR1 oligonucleotide treatment causes inhibition of cell
cycling.23 24
It is established that TfR1 is expressed in colonocytes and
overexpressed in CRC and is likely to play a role in the iron
Abbreviations: CRC, colorectal cancer; DCYTB, duodenal cytochrome
b; DMT1, divalent metal transporter 1; TfR1, transferrin receptor 1;
HEPH, hephaestin; FPN, ferroportin; PCR, polymerase chain reaction;
CK, cytokeratin; PBS, phosphate buffered saline; DAB
diaminobenzidine, ; LGD, low grade dysplastic adenomas, HGD, high
grade dysplastic adenomas
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nutrition of these cells.25 Other iron transport proteins are
also expressed in the colon26 27 but to date there is no evidence
that any of these proteins are perturbed in human CRC. More
recently, it has been demonstrated that elevated levels of
intracellular iron in a hepatocyte cell model can modulate
E-cadherin expression, an adhesion protein commonly
repressed in epithelial carcinogenesis.28 29
We hypothesised that, while malignant colonocytes
express increased levels of the proteins required for cellular
iron uptake, there is inadequate expression of the protein
export machinery causing these colonocytes to accumulate
iron. We believe that this resulting accumulation in cellular
iron causes changes to cell behaviour, which may contribute
to the malignant progression of this disease.
To test this hypothesis, the aims of this study were twofold:
(i) to examine expression of proteins involved in iron uptake
(DCYTB, DMT1, and TfR1), export (FPN, HEPH), and storage
(ferritin) in the progression from normal colon to CRC in
human tissue samples; and (ii) to examine the effect of iron
loading of colorectal cell lines on proliferation and expression
of E-cadherin, an adherens junction protein which is
repressed in colorectal carcinogenesis
MATERIAL AND METHODS
Ethics
This work was carried out in accordance with the declaration
of Helsinki (2000) of the World Medical Association. Ethics
approval for this study was approved by South Birmingham
LREC No 05/Q2702/17. All patients provided informed
written consent.
Patient tissue
Colorectal cancer resection specimens
Samples (n = 11) of colorectal carcinoma matched with normal
colonic mucosa from the same resection specimen were
collected during surgery and each tissue specimen was divided
into three: one third for RNA extraction, one third for western
blotting, and the final portion for immunohistochemistry.
Archived tissue
Paraffin sections of normal colon from patients with colo-
rectal carcinoma (n = 20), low grade dysplastic adenomas
(LGD) (n = 20), high grade dysplastic adenomas (HGD)
(n = 20), and CRC (n = 20) were identified within the
archived tissue bank (Department of Pathology, Queen
Elizabeth’s Hospital, Birmingham, UK) and processed for
immunohistochemistry.
Real time polymerase chain reaction (PCR)
Real time PCR was performed, as described previously,30 on
CRC specimens described above. All reactions were per-
formed using 18S ribosomal RNA as an internal standard (PE
Biosystems, Roche, USA), and contained one of the sets of
probes and primers listed in table 1.
Western blotting
Western blotting was performed on colorectal cancer speci-
mens described above, as previously reported,30 with a rabbit
polyclonal antibody to either: (i) DMT1 (1:1000 dilution)31;
(ii) FPN (clone 3566, 1:1000 dilution)21; (iii) ferritin (1:2500
dilution; Sigma UK); (iv) HEPH (1:200 dilution; HEPH11-A,
ADI, USA); or (v) DCYTB (clone 834, 1:1000 dilution),15
or a monoclonal antibody to (i) TfR1 (11000 dilution;
Zymed Laboratories, San Francisco, California, USA) or (ii)
E-cadherin (1:1000 dilution; BD Biosciences, Cowley, Oxford,
UK). A cytokeratin 19 (CK-19) monoclonal antibody (1:2000
dilution; Oncogene Research Products, USA) was employed
for normalisation of epithelial protein loading.
Immunoreactive bands were then subject to densitometry
using NIH Image 1.62 software.
DAB enhanced Perls’ Prussian blue staining
Paraffin sections were dewaxed, washed in dH2O, and
incubated in a 1:1 solution of 4% HCl and 4% ferrous cyanate
for 30 minutes. Following incubation in phosphate buffered
saline (PBS) for five minutes, sections were incubated in DAB
(diaminobenzidine) Chromogen Solution 506 (Dako, Ely,
Cambridgeshire, UK) (1:200) for 15 minutes followed by a
further incubation for 15 minutes in DAB (1:50) in substrate
buffer (Dako ChemMate). Sections were then either counter-
stained with haematoxylin for 30 seconds or processed for
immunocytochemistry. Images were visualised using a Nikon
Eclipse E600 microscope and digital image taken using a
Nikon DXM1200F camera (Surrey, UK). Nikon ACT-1 version
2.62 software was used for image acquisition (Surrey, UK).
Immunocytochemistry
Briefly, sections were dewaxed and incubated in hydrogen
peroxide/methanol (1:10) for five minutes followed by
15 minutes of microwave antigen retrieval using 0.1 M citric
acid pH 6.0. Sections were blocked with normal goat serum
for 30 minutes and then incubated for one hour with rabbit
polyclonal antibodies to: (i) DCYTB (1:200, clone 834), (ii)
DMT1 (1:3000), (iii) FPN (1:200 clone 3566), (iv) ferritin
(1:1000, F-5012; Sigma , UK), (v) HEPH 1:50 (HEPH11-A,
ADI, USA), or monoclonal antibodies to (vi) TfR1 antibody
Table 1 Probes and primers used for real time polymerase chain reaction
Probe (59FAM 39TAMRA) Forward primer, 59-39 Reverse primer, 59-39
SLC11A2 (DMT1) IRE+ve CTC TAT CAG GCT TAG GAT TCT TTG
AAC TTA TTT CCA CTT T
CCA TAT GAA ATA TAA AAT GAA GAG
ACA CCT A
CCC CTC TTA ACT TCC ACT GAG
AAA
SLC11A2 IRE2ve CCC ACC CAT AAC AGT CAT ACA
CTC CCA GAG T
TGG GAA GGG TGT TTC AAA ACT G CCA TCA GAG GCC AAT CGT TTA
SLC40A1 (FPN) AGGATTGACCAGTTAACCAACATCT
TAGCCCC
AGC AAA TAT GAA TGC CAC AAT
ACG
CAA ATG TCA TAA TCT GGC CAA
CAG
Ferritin CCA ACG AGG TGG CCG AAT CTT
CCT T
GGA ACA TGC TGA GAA ACT GAT
GAA
CAT CAC AGT CTG GTT TCT TGA
TAT CC
HEPH ACA GTG ACA TAG TGG CTT CCA
GCT TCT TAA AGT CTG
GGA AGA AAT GTC ATC ACG AAC
CA
TCC CCC TAT CCG GTT CTT G
TFRC (TFR1) AAA GAC AGC GCT CAA AAC TCG
GTG ATC ATA G
CGT GAT CAA CAT TTT GTT AAG
ATT CA
CCA CAT AAC CCC CAG GAT
TCT
CYBRD1 (DCYTB) CCA GGG CAT CGC CAT CAT CGT CATGGTCACCGGCTTCGT CAG GTC CAC GGC AGT CTG TA
CDX-2 CGA GCT AGC CGC CAC GCT GG CTA CAT CAC CAT CCG GAG GAA CAG ATT TTA ACC TGC CTC
TCA GAG A
E-cadherin AAA TTC ACT CTG CCC AGG ACG
CGG
GGC GCC ACC TCG AGA GA TGT CGA CCG GTG CAA TCT T
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(1:40, Novocastra, UK) or E-cadherin (BD Biosciences;
1:200). Following extensive washing, sections were incu-
bated with the appropriate peroxidase linked secondary
antibody and immunoreactivity was visualised using DAB
reagent followed by counterstaining with haematoxylin.
Small bowel mucosa was included as a positive control, and
omission of primary antibody was used as a negative control.
Cellular localisation (nuclear, cytoplasmic, cell surface)
and staining intensity, graded as 0 (no expression), 1 (weak),
2 (moderate), or 3 (strong) expression, were scored inde-
pendently by three observers (MB, SH, and CT).
In experiments where DAB enhanced Perls’ Prussian blue
stain and immunocytochemistry were performed on the same
section, Prussian blue staining was carried out prior to
immunocytochemistry. The procedure was as described
above, but a Vector VIP peroxidase substrate kit (Vector
Laboratories UK, Orton Southgate, Peterborough, UK) was
substituted for the DAB reagent to allow colour discrimina-
tion for visualisation purposes.
Tissue microarrays
A separate set of CRC samples (n = 250) collected between
2000 and 2005 for which complete clinical data were
available were used to evaluate the association between iron
transporter levels and prognostic factors. The prognostic
factors included Dukes’ staging (A–D), extent of vascular
invasion (none, moderate, focal, or extensive), nodal
involvement, sex, and age. To facilitate the screening of
multiple tissue blocks from each patient, tissue microarrays
were prepared containing four representative samples of
tumour per patient. Sections (4 mm) were cut from each array
block onto Superfrost positively charged slides (Surgipath
Europe Ltd, Bretton, Peterborough, UK) and heated for one
hour at 60 C˚ followed by processing for immunohistochem-
istry and scoring as described above.
Cell culture
Cell lines SW480 and Caco-2 were routinely cultured in
Dulbecco’s modified Eagle’s medium (Invitrogen Ltd, Paisley,
UK) with 10% fetal calf serum supplemented with 100 U/ml
penicillin and 0.1 mg/ml streptomycin. SW480 cells were iron
loaded on reaching 70% confluence while Caco-2 cells were
grown for 14 days after reaching confluence.
Iron loading
Cells were challenged with either growth medium alone
(control) or iron loaded medium (growth medium supple-
mented with 100 mM FeSO4 and 10 mM sodium ascorbate)
for between one and 24 hours. FeSO4 (100 mM) was chosen
as this concentration has been used in other studies and was
shown to be the optimal concentration for E-cadherin
repression and induction of proliferation (data not shown).
Immunofluorescence
Cells were fixed in methanol/acetone, blocked (20% goat
serum in 1% bovine serum albumin/PBS) and incubated with
a monoclonal anti-E-cadherin antibody (BD Biosciences
1:500) for one hour prior to labelling with FITC goat
antimouse (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, Pennsylvania, USA; 1:500). Cells were then
washed and incubated in DAPI (1:10 000) for one minute
prior to visualisation. Omission of the primary antibody was
employed as a negative control.
E-cadherin promoter assay
The wild-type human E-cadherin promoter sequence (2301/
+21) cloned into pGL3basic luciferase reporter (EproWT) was
a kind gift from Prof Frans van Roy.32 pGL3 basic, which
contains the firefly luciferase gene without a promoter
sequence, was used as a control, with Renilla luciferase
plasmid (pRL TK) used as a transfection control. Caco-2 cells
were transiently transfected with 1 mg EproWT or pGL3 basic
NC
CC
A
DC
B
Figure 1 Elevated diaminobenzidine (DAB) enhanced Prussian blue staining in colorectal carcinoma. Sections of normal colon (n = 20) and colorectal
cancer (CRC, n = 20) were subject to DAB enhanced Perl’s Prussian blue staining. In normal colonic epithelium there was no detectable staining (A–B)
while in CRC, diffuse cytoplasmic staining was seen (C–D). (A, C, original magnification640; B–D original magnification6100).
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in the presence of 0.1 mg pRL TK using standard calcium
phosphate transfection methods. Sixteen hours post transfec-
tion, the culture medium was replaced with either fresh
medium or iron loaded medium for 24 hours and then cells
were assayed for firefly and Renilla luciferase activities using
the dual reporter assay kit Stop ‘N’ Glow (Promega,
Southampton Science Park, Southampton, UK) according to
the manufacturer’s instruction. Firefly luciferase activity was
normalised to Renilla luciferase activity as a transfection
control. Promoter activity was expressed as a fold change in
relative luciferase units compared with that obtained in
pGL3basic control transfected cells. Results shown represent
the means (SEM) of six independent experiments.
Proliferation assay
The effect of cellular iron loading on proliferation was
examined using a bioluminescent technique to measure
changes in cellular ATP (ViaLight HS; LumiTech,
Nottingham, UK) as previously described.33 ATP levels were
recorded in relative luciferase units and proliferation was
expressed as a percentage of control.
NC
CC
FPN    HEPH Ferritin control
DCYTB TfR1 DMT1                     control
NC
CC
Figure 2 Immunolocalisation of iron transport proteins in normal colon and colorectal cancer. Paraffin sections of normal colon associated with
colorectal cancer (NC) and colorectal cancer (CC) were subjected to immunohistochemistry using antibodies to various proteins of iron metabolism.
Duodenal cytochrome b (DCYTB), divalent metal transporter 1 (DMT1), ferroportin (FPN), ferritin, transferrin receptor 1 (TfR1), and hephaestin (HEPH)
were all weakly expressed in NC. With the exception of ferritin and HEPH, there was strong immunoreactivity in CC. As antibodies used were either
mouse monoclonal or rabbit polyclonal antibodies, negative controls included omission of primary antibody followed by processing with either a rabbit
secondary (polyclonal 2ve control) or mouse secondary (monoclonal 2ve control) antibody, as described in material and methods. Arrows denote
areas of positivity (original magnification660).
Table 2 Semiquantitative analysis of immunoreactivity
of iron transport proteins in progression from normal
colon to colorectal carcinoma
NC LGD HGD CRC
DCYTB 1.05 1.84 1.7 2.25*
TfR1 1.30 0.40 0.50 2.08*
DMT1 1.20 0.80 1.45 2.10*
FPN 1.36 1.64 2.55* 2.10*
HEPH 1.23 1.50 1.54 0.82*
Ferritin 0.68 0.20* 0.40* 0.80
Paraffin sections of normal colon (NC) (n = 20), low grade dysplastic
adenomas (LGD) (n = 20), high grade dysplastic adenoma (HGD)
(n = 20), and colorectal carcinoma (CRC) (n = 20) were all subject to
immunohistochemistry with antibodies to duodenal cytochrome b
(DCYTB), transferrin receptor 1 (TfR1), divalent metal transporter 1
(DMT1), ferroportin (FPN), hephaestin (HEPH), and ferritin.
Staining intensity was graded as 0 (no expression), 1 (weak), 2
(moderate), or 3 (strong) expression.
The mean of each group is presented and numbers in bold denote a value
that is significantly different when compared with NC (*p,0.05).
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Ferrozine assay
Non-haem iron was assayed, as previously described,34 and
cellular iron content was expressed as nmol of iron per mg
protein. Protein concentrations were assessed by Bradford
assay (Bio-Rad Laboratories Ltd, Hemel Hempstead,
Hertfordshire, UK).
Statistics
All experimental errors are shown as two standard error of
the mean (representing 95% confidence intervals). Statistical
significance was calculated by use of the unpaired Student’s
t test and the Mann-Whitney test where appropriate.
Correlation was evaluated using Pearson’s correlation
Figure 3 mRNA expression of iron transport genes in normal colon and colorectal carcinoma. Real Time polymerase chain reaction was used to
examine expression of genes encoding various iron transport proteins in colorectal carcinoma specimens 1–11 (C1–C11) compared with their own
normal tissue control (NC), normalised to 1. Transferrin receptor 1 (TfRC), CYBRD1 (duodenal cytochrome b), and SLC11A2 (divalent metal transporter
1; both IRE containing and non-IRE variants) mRNAs were overexpressed in over 73% of cancers examined compared with their normal colonic
control. SLC40A1 (ferroportin) and FTH1 (ferritin) mRNA expression were variable within the 11 samples. Hephaestin (HEPH) and CDX-2 mRNA
expression were both mostly reduced. Values are mean (2 SEM).
A role for iron in E-cadherin repression 1453
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coefficient and a one way ANOVA test. Comparison between
categorical variables was made using a x2 analysis. All
analyses were performed using SPSS version 10.0 (SPSS Inc,
North Carolina, USA). Significance was accepted at p,0.05.
RESULTS
Iron content of colorectal cancer tissue
Whether colonocytes in CRC are relatively iron deficient or
iron rich is unclear at present. To answer this question, we
initially stained sections of CRC and matched normal colonic
mucosa (n = 20) for iron by DAB enhanced Perls’ Prussian
staining.
In normal colonic epithelium there was no detectable DAB
enhanced Perl’s Prussian blue staining (fig 1A–B), and only
very low levels of iron were apparent in LGD and HGD.
However, in all of the CRCs there was evidence of more
intense staining which was diffuse throughout the cell
cytoplasm (fig 1C–D).
To test whether the observed colonocyte iron accumulation
could be attributed to changes in iron transport proteins,
immunohistochemistry with semiquantitative analysis was
performed.
Immunolocalisation of iron metabolism proteins in
archived tissue
Localisation of the proteins involved in cellular iron uptake
(DCYTB, DMT1, and TfR1), iron export (FPN and HEPH), and
iron storage (ferritin) was examined in archived tissue
specimens of: (i) normal colonic mucosa (adjacent to
colorectal carcinoma) (normal colon); (ii) LGD; (iii) HGD;
and (iv) CRC (fig 2). Staining intensity for all specimens was
also scored and the data are presented in table 2.
In normal colonic mucosa, DCYTB was weakly expressed
on the colonic surface epithelium with no expression at crypt
bases. Expression was predominantly apical and vesicular.
This pattern of immunoreactivity was retained in LGD and
HGD, and in CRC. However, there was significantly higher
DCYTB immunoreactivity in CRC compared with normal
colon (p,0.05). DMT1 was expressed weakly on the surface
epithelium of normal mucosa and in the top third of the
crypts with predominantly apical diffuse cytoplasmic stain-
ing. No staining was seen in crypt bases. Similar immuno-
reactivity was observed in LGD and HGD. However, stronger
cytoplasmic staining for DMT1 was seen in CRC specimens
compared with normal colon (p,0.05). TfR1 was predomi-
nantly localised at the basolateral membrane of crypt
colonocytes, strongest immunoreactivity being at the crypt
base with a gradation to weak immunoreactivity on surface
epithelium. In CRC there was marked overexpression of TfR
compared with normal colon (p,0.05), with immunoreac-
tivity predominantly on the plasma membrane.
FPN was predominantly localised on the basolateral
membrane of the colonocyte with a gradation of immuno-
reactivity from high to low from the surface epithelium to the
base of the crypt. A similar profile of expression was observed
in dysplastic adenomas. Interestingly, there was strong
cytoplasmic immunoreactivity in CRC compared with normal
colon (p,0.05) although poorly differentiated cells at
invasive fronts showed weaker immunoreactivity (data not
shown). HEPH was observed only on the surface epithelium,
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Figure 4 Protein expression of iron transporters in normal colon and colorectal carcinoma. Expression of divalent metal transporter 1 (DMT1),
transferrin receptor 1 (TfR1), duodenal cytochrome b (DCYTB), ferritin, hephaestin (HEPH), and ferroportin (FPN) protein was studied in normal colon
(NC) and colorectal cancer (CC) by western blotting and quantitated by densitometry. A representative western blot for each protein is shown and
cytokeratin 19 (CK19) employed for normalisation. Relative protein expression was normalised to 1.0 (100%) of controls. Values are mean (2 SEM).
*p,0.05, Student’s t test.
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not in crypts. Intracellular localisation of HEPH was
predominantly basal with some weak supranuclear staining.
A similar pattern of expression was observed in both LGD
and HGD while in CRC there was only weak diffuse
cytoplasmic staining (p,0.05).
Very weak immunoreactivity for ferritin was observed in
normal colonic mucosa with most positivity observed in non-
epithelial cells within the lamina propria. In LGD and HGD,
ferritin immunoreactivity was almost completely absent
within colonocytes and was shown to be significantly lower
compared with normal colon, while ferritin expression was
unchanged in colorectal carcinomas compared with normal
colon (table 2).
These results suggest that the cellular iron import
machinery is overexpressed in CRC while the capacity of
cells to export iron is reduced.
mRNA and protein expression of iron metabolism
molecules in colorectal cancer resection specimens
To extend the immunohistochemistry results described
above, we examined mRNA and protein expression of iron
transport proteins in CRC resection specimens (CRC)
matched with normal colonic mucosa (n = 11) by real time
PCR (fig 3) and western blotting (fig 4), respectively.
TfRC, CYBRD1, and SLC11A2 mRNAs were overexpressed in
over 73% of cancers examined compared with their internal
matched normal colonic controls (fig 3). As four SLC11A2
splice variants have been described,35 (59 variants (exon 1A or
1B) and 39UTR variants (IRE+ve or IRE2ve)) we investigated
mRNA expression of these variants and showed that both
IRE+ve and IRE2ve variants were overexpressed in these
cancers (fig 3). Additionally, we were able to show over-
expression of the 59 1B variant in tumours which showed
overexpression of the 39 variants but we were unable to
detect any 1A variant in any sample (results not shown).
To complement the mRNA analyses, we examined all 11
cancer samples with their matched normal colonic mucosa
control for protein expression (fig 4). DCYTB, DMT1, and
TfR1 were overexpressed with mean fold increases of 1.6,
2.05, and 1.7 (p,0.05), respectively (fig 4), consistent with
the immunohistochemistry data.
Analysis of SLC40A1 mRNA expression demonstrated over-
expression in 4/11 and reduced expression in 2/11 CRCs, the
remainder being unchanged. HEPH mRNA was overex-
pressed in only 3/11 cancers while the majority of cancer
specimens (7/11) showed reduced expression (fig 3).
Moreover, a correlation between SLC40A1 and HEPH was
observed (Pearson correlation coefficient r2 = 0.57, p = 0.007,
ANOVA). As it has recently been reported that hephaestin
can be regulated by the transcription factor CDX-2, we
examined CDX-2 mRNA and compared the findings to
hephaestin (fig 3).36 A significant correlation between
HEPH and CDX-2 mRNA expression was observed (r2 =
0.72, p = 0.001) although no significant correlation between
CDX-2 and SLC40A1 mRNA expression (r2 = 0.23, p = 0.22)
was apparent, consistent with previous findings.36 FPN
protein was overexpressed with a mean fold increase of
2.07 (p,0.05) while HEPH protein was decreased (mean 0.81
fold; p,0.05) (fig 4). In summary, HEPH is repressed at both
the mRNA and protein levels while FPN protein data suggest
Table 3 Semiquantitative analysis of immunoreactivity of iron transport proteins in a
colorectal carcinoma tissue array
All samples
(mean (SD))
Female
(mean (SD))
Male
(mean (SD))
HEPH
Duke’s stage
A 1.08 (0.60) 1.09 (0.7) 1.08 (0.53)
B 0.95 (0.66) 0.95 (0.59) 0.91 (0.72)
C 0.91 (0.69) 0.89 (0.68) 0.93 (0.71)
Vascular invasion
None 0.97 (0.66) 0.94 (0.63) 0.99 (0.67)
Moderate 0.94 (0.64) 1.28 (0.56) 0.65 (0.35)
Focal 0.97 (0.71) 0.94 (0.68) 1.04 (0.77)
Extensive 0.50* (0.43) 0.50 (0.07) 0.50* (0.54)
Nodal involvement
Negative 0.98 (0.7) 0.95 (0.61) 1.00 (0.68)
Positive 0.91 (0.64) 0.94 (0.69) 0.91 (0.7)
FPN
Duke’s stage
A 2.08 (0.87) 2.18 (1.0) 2.01 (0.76)
B 2.46 (0.85) 2.52 (0.98) 2.36 (0.83)
C 1.70* (0.75) 1.84 (0.77) 1.59* (0.72)
Vascular invasion
None 2.01 (0.84) 2.14 (0.92) 1.97 (0.78)
Moderate 1.96 (0.8) 2.10 (0.82) 1.73 (0.77)
Focal 1.86 (0.94) 1.78 (1.11) 2.06 (0.87)
Extensive 2.14 (0.85) 2.34 (0.76) 1.34 (0.82)
Nodal involvement
Negative 2.28 (0.87) 2.36 (0.97) 2.22 (0.75)
Positive 1.70* (0.85) 1.90 (0.8) 1.44* (0.78)
Colorectal cancers (n = 250) for which complete clinical data were available (extent of vascular invasion, nodal
involvement, Dukes’ stage, sex, and age) were used to evaluate the association between iron transporter levels and
these prognostic factors.
Immunohistochemistry was performed with antibodies to duodenal cytochrome b (DCYTB), divalent metal
transporter 1 (DMT1), ferroportin (FPN), ferritin, transferrin receptor 1 (TfR1), and hephaestin (HEPH). Staining
intensity was graded as 0 (no expression), 1 (weak), 2 (moderate), and 3 (strong) expression. As there were no
statistically significant associations between DCYTB, DMT1, ferritin, and TfR1 expression and any prognostic factor,
these values have not been presented.
However, both FPN and HEPH significantly correlated with vascular invasion, Dukes’ stage, and nodal
involvement. The mean of each group is presented and numbers in bold denote values significantly different from
control (*p,0.05; Student’s t test).
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overexpression consistent with the immunohistochemistry
data.
FTH1 mRNA expression varied within the 11 samples
studied with roughly an equal number showing over- and
reduced expression (fig 3). Furthermore, on western blotting
there was no change in ferritin protein levels between normal
colon and CRC specimens (fig 4), consistent with the
immunohistochemistry data.
For DCYTB, DMT1, TfR1, and HEPH, a positive correlation
between mRNA and protein expression was observed for each
CRC specimen (p,0.05). No such correlation was seen for FPN.
These data support the hypothesis that in CRCs there is
overexpression of the proteins implicated in cellular iron
uptake and that levels of HEPH are repressed while those of
FPN are elevated.
Tissue microarray
This study provides evidence that iron transport proteins are
modulated in the malignant progression of disease. We
further sought to determine whether any changes in protein
expression were associated with prognostic factors such as
stage of disease, extent of vascular invasion, and or
metastasis by utilising a tissue array of 250 CRCs with
known outcome.
The tissue microarray analysis showed no significant
changes in staining intensity for DMT1, TfR1, DCYTB, or
ferritin with respect to clinical outcome. However, HEPH
expression was reduced in cancers with extensive vascular
invasion compared with cancers with no vascular invasion
(p,0.05) and this finding was observed in both males and
females (p,0.05) (table 3). Similarly, FPN was repressed in
Dukes’ stage C CRCs compared with earlier stage cancers
(p,0.05). Not surprisingly, as Dukes’ stage C is classified as
positive nodal involvement, statistical repression in FPN was
also observed in all patients with nodal involvement
(p,0.05). Interestingly, this was confined to males only,
with no significant change observed for females (table 3).
Modulation of cellular iron levels and its effect on
cellular proliferation
To determine whether iron loading exerted any effects on
cellular proliferation, we experimentally iron loaded the well
and poorly differentiated colorectal cell lines Caco-2 and
SW480, respectively.
Caco-2 and SW480 cells were iron loaded and iron content
was measured using a ferrozine assay (fig 5). Control non-
iron loaded cells showed low iron levels (means 0.002 and
0.004 nmol/mg protein for Caco-2 and SW480 cells, respec-
tively) while on iron loading there was a significant increase
in iron levels (p,0.05, means 0.086 and 0.212 nmol/mg
protein, respectively) in both Caco-2 and SW480 cells (fig 5A).
Increased cellular iron was associated with a significant
increase in cellular proliferation compared with controls
(p,0.05) (fig 5B).
Modulation of cellular iron levels and its effect on the
cell adhesion molecule E-cadherin
As previous studies have shown that a common event in
nearly all epithelial malignancies, including CRC is repression
of the cell adhesion molecule E-cadherin, we examined
whether loading cells with iron could reduce expression of
E-cadherin.
Iron loading of Caco-2 and SW480 cells for 24 hours
resulted in a 37% (p,0.05) and 48% (p,0.05) decrease in
E-cadherin mRNA, respectively (fig 6A, B). To ensure that
this observation was not a global mRNA repression, we also
Figure 5 Iron loading of Caco-2 and SW480 cells causes increased
proliferation. (A) Caco-2 and SW480 cells were either cultured in
growth medium (Control) or growth medium supplemented with 100 mM
FeSO4 for 24 hours (IL). Iron loading for 24 hours resulted in iron
accumulation in both Caco-2 and SW480 cells. Values are mean (2
SEM). *p,0.05 using the Student’s t test. These data are the mean of
three independent experiments, each performed in triplicate. (B) Iron
loading of Caco-2 and SW480 cells resulted in a marked induction in
cellular proliferation. Values are mean (2 SEM). *p,0.05 using
Student’s t test. These data are the mean of three independent
experiments.
Figure 6 Iron loading decreases E-cadherin mRNA expression. To determine whether iron loading modulated expression of E-cadherin mRNA,
control and 24 hour iron loaded (IL) Caco-2 (A) and SW480 (B) cells were assessed by real time polymerase chain reaction. Iron loading of both cell
lines resulted in a marked decrease in E-cadherin mRNA expression. Relative gene expression was normalised to 1.0 (100%) of controls. Values are
mean (2 SEM). *p,0.05 using Student’s t test. These data are the mean of three independent experiments.
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examined other transcripts, including actin, and b- and c
catenin, and these showed no changes (results not shown).
Iron loading caused a significant decrease in E-cadherin
protein expression compared with non-iron loaded controls
in both Caco-2 and SW480 cells (30% and 54%, respectively;
p,0.05) (fig 7A–D). Immunofluorescence for E-cadherin in
Caco-2 and SW480 cells showed that while there was
preserved E-cadherin immunoreactivity on the cell surface
in both control and iron loaded cells, the intensity of the
staining in iron loaded cells was markedly lower. This
was more pronounced in SW480 cells than in Caco-2 cells
(fig 7E–F).
Figure 7 Iron loading reduces E-cadherin protein expression. Extracts from control and 24 hour iron loaded (IL) Caco-2 (A) and SW480 (B) cells
were subjected to western blotting. (A, B) Representative E-cadherin immunoblots with cytokeratin 19 (CK-19) employed for normalisation. The
E-cadherin immunoreactive band (Mr 120 000) was quantitated by densitometry and controls normalised to 1 (C, D). There was a marked decrease in
E-cadherin protein expression following iron loading. Values are mean (2 SEM). *p,0.05 using Student’s t test. Data are the mean of three
independent experiments. Additionally, immunofluoresence staining demonstrated that while control Caco-2 and SW480 cells showed the expected
cobblestone network pattern of cell surface staining indicative of E-cadherin, expression of E-cadherin in iron loaded cells was much reduced (E, F)
(original magnification640).
Figure 8 Iron loading causes a decrease in E-cadherin promoter activity. Caco-2 (A) and SW480 (C) cells were transiently transfected with 1 mg
EproWT (containing the wild-type human E-cadherin promoter sequence linked to a firefly luciferase reporter gene) and 0.1 mg pRL-TK (Renilla
luciferase plasmid used as a transfection control). Sixteen hours post transfection, culture medium was replaced with either control or iron loaded (IL)
medium. After 24 hours cells were harvested, lysed, and luciferase activity analysed. The control value was set at 100% for normalisation purposes.
Iron loading resulted in marked repression in E-cadherin promoter activity. Data shown represent the mean (2 SEM) of six independent experiments.
*p,0.05 using Student’s t test.
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To ascertain whether the changes in E-cadherin mRNA
levels were due to changes in E-cadherin promoter activity,
we performed an E-cadherin promoter assay using the wild-
type human E-cadherin promoter sequence (2301/+21)
cloned into the luciferase reporter vector pGL3basic (fig 8).32
We demonstrated a significant reduction in E-cadherin
promoter activity in response to 24 hours of iron loading in
both Caco-2 and SW-480 cells (22% and 48% reduction,
respectively; p,0.05) (fig 8A, B).
E-cadherin expression and cellular iron loading in
colorectal carcinoma specimens
To support the observation that in vitro cellular iron loading
causes a decrease in E-cadherin expression, we sought to
determine if this was also the case in vivo. This was
addressed by staining paraffin sections of CRC (n = 20)
using the DAB enhanced Perls’ Prussian blue procedure
immediately followed by immunohistochemistry for
E-cadherin on the same section (fig 9). In all CRCs there
was a reciprocal relationship between iron staining and
E-cadherin expression. Where there was positive DAB
enhanced Perls’ Prussian blue staining there was no
E-cadherin immunoreactivity observed (fig 9A). Conversely,
in areas of strong E-cadherin immunoreactivity, little if any
iron staining was apparent within those colonocytes (fig 9B).
DISCUSSION
Accumulated data suggest that high dietary iron intake is a
major risk factor for CRC.4 37 38 In particular, while colonic
luminal iron is likely to cause free radical damage leading to
inflammation and ultimately cell damage, luminal iron
appears to exert a more potent effect in the presence of a
background molecular lesion.10 13 This is supported by the
observation of an increased risk of CRC in individuals with an
existing HFE mutation.10 Furthermore, data from animal
models indicate that iron exacerbates colorectal tumorigen-
esis induced by carcinogens such as DMH or DSS, although
the mechanism behind this remains obscure.6 12 13
While this evidence suggests a role for iron in colorectal
carcinogenesis, how iron is implicated at the cellular and
molecular level is not known. We hypothesised that changes
in expression of the proteins involved in epithelial iron
transport could cause accumulation of iron in colonocytes
and this could potentiate malignant transformation and
tumour progression.
Our initial data indicated that normal human colon
expresses DCYTB, DMT1, FPN, ferritin, HEPH, and TfR1,
consistent with previous investigations which have shown
DCYTB, FPN, and HEPH expression in rodent colon.19 26 36 We
observed DCYTB, DMT1, HEPH, and FPN expression pre-
dominantly on the luminal surface of the colonic epithelium,
with decreasing expression towards the crypts. Conversely,
and consistent with previous observations, TfR1 expression
was mainly at the bases of the crypts.39 This localisation in the
proliferative compartment suggests a role for TfR1 in the
supply of iron for cell growth and proliferation.40 These data
add weight to existing literature showing that the colon is
capable of absorbing iron.27 41–43
Of particular interest is modulation of these proteins in the
malignant progression of normal colon to cancer. Data from
our characterisation of iron transporter expression in CRC
specimens indicate that DMT1 is overexpressed and immuno-
histochemical results suggest that this is a late feature of
colorectal tumorigenesis as no induction is seen in LGD or
HGD specimens. As four splice variants of DMT1 have been
described,35 we examined the expression profile of each
variant and found only the exon 1B 59 variant. Both the 39
IRE- and non-IRE variants were detected in most of the 11
cancers investigated. This, in conjunction with the observa-
tion of increased intracellular iron accumulation in CRC
specimens compared with normal samples, mitigates against
a predominant IRE/IRP mediated induction of DMT1. We
suggest that there is likely to be at least one other regulatory
mechanism operating to modulate expression of DMT1.
Interestingly, we also found a dramatic induction of TfR1
in CRC specimens. This is well recognised in the literature
both in colorectal and other cancers, and indeed TfR1 has
been suggested as a target for tumour chemotherapy in the
past.25 44 However, as we have demonstrated that colonocytes
in CRC are iron rich, one might expect to see reduced TfR1
expression. As this is not the case, TfR1, like DMT1, may also
be regulated by other intracellular and possibly extracellular
signals which increase its expression independent of cellular
iron status.
Our findings on expression of the putative ferric reductase,
DCYTB, were surprising. DCYTB has been suggested to play a
pivotal role in small intestinal iron absorption in the
reduction of ferric to ferrous iron. Although we found
overexpression of DCYTB in the majority of CRC specimens,
the protein appears to be localised in cytoplasmic vesicles
rather than at the cell membrane. Furthermore, DCYTB
staining was observed at sites of invasion far from luminal
surfaces. This would mitigate against a role for DCYTB in
DMT1 mediated iron uptake in the human colon. Thus
DCYTB may have a cellular function separate from its
postulated role in ferric iron reduction.45
A B
Figure 9 Enhanced Prussian blue staining and E-cadherin immunoreactivity in colorectal carcinomas. Paraffin sections of colorectal carcinomas were
subjected to Prussian blue staining followed by immunohistochemistry for E-cadherin. (A) In discrete areas of the colorectal carcinoma where there was
positive diaminobenzidine (DAB) enhanced Perls’ Prussian blue staining (brown) there was little or no evidence of E-cadherin staining. (B) Conversely,
in areas of E-cadherin plasma membrane staining (purple) little if no DAB enhanced Perls’ Prussian blue staining was observed. Arrows denote areas of
positivity (original magnification 640).
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Thus consistent with our hypothesis, there is indeed
overexpression of the proteins involved in iron uptake. This
would clearly cause increased entry of iron into cells. If these
cells are indeed highly proliferative and have adequate iron
export machinery, why is it that we observe increased
intracellular iron in CRCs? To address this we assessed levels
of the main proteins involved in iron export, HEPH and FPN,
to determine whether their expression was altered.
Expression of HEPH was lower in CRCs relative to normal
colon at both the mRNA and protein levels. In particular,
when utilising a tissue microarray containing 250 CRCs, we
were able to show that reduced HEPH expression was
associated with extensive vascular invasion. Consistent with
the recent finding that the transcription factor CDX-2 is able
to regulate HEPH expression,36 we found coordinate expres-
sion of CDX-2 and HEPH in the majority of cancers
examined. Hinoi et al proposed that elevated intracellular
iron induces CDX-2 which in turn promotes HEPH expres-
sion.36 In concert with FPN, this would promote iron export.
We suggest that loss of CDX-2 in CRCs prevents high
intracellular iron from inducing HEPH expression thus
sustaining the high iron levels in colonocytes.46 However,
this does not explain the decrease in HEPH expression
observed in CRCs.
Expression of the mRNA encoding the iron export protein
FPN largely paralleled expression of HEPH mRNA, although
paradoxically FPN protein levels increased while those of
HEPH decreased. Of particular interest, FPN was the only
iron transport protein to show overexpression in adenomas
with HGD. Despite this overexpression of FPN, as the protein
FPN was predominantly localised intracellularly, we propose
that it is non-functional in cellular iron export. Data from
analysis of the colon cancer tissue array indicate that there
was loss of cytoplasmic FPN expression in advanced (Dukes’
C) cancers. In tumours with nodal involvement, this loss of
FPN appeared to be restricted to men. Why specimens from
women with such advanced CRC retain FPN is unexplained.
Thus in CRCs there is overexpression of the iron uptake
proteins DMT1 and TfR1 and likely reduced iron export with
HEPH expression reduced and FPN probably non-functional
due to inappropriate cytoplasmic localisation. Furthermore,
in advanced cancers, as well as a reduction in HEPH there
was also a decline in FPN expression. This suggests that while
intracellular iron entry is likely to be accelerated, iron export
is abrogated creating accumulation of cellular iron. This is
supported by the increased staining for iron observed in these
cancers. Apparently inconsistent with this hypothesis is the
observation that ferritin expression is unchanged in CRCs. In
fact, in LGD and HGD lesions, ferritin staining was reduced
compared with controls. It is possible that the lack of
elevation of ferritin in the face of increased intracellular iron
content in cancers reflects other competing pathways
modulating ferritin expression. For example, it is well
recognised that inflammatory cytokines such as tumour
necrosis factor a a can modulate ferritin expression,18 and
there is also evidence that c-myc, an oncogene overexpressed
in CRCs, can repress ferritin.47
To investigate what effect this increased intracellular iron
has on cell phenotype, we studied experimentally iron loaded
colorectal tumour cell lines. We were able to load SW480 and
Caco-2 cells with iron to levels similar to those detected in the
11 CRC specimens studied (data not shown) and both lines
showed increased proliferation in response to loading.
Interestingly, Caco-2 cells, which were iron loaded to a lesser
extent than SW480 cells, showed a more dramatic increase in
cellular proliferation. As Caco-2 cells are well differentiated
while SW480 cells represent a poorly differentiated lineage,
our observations may indicate that the cellular response to
iron is dependent on differentiation status. Whether iron
mediates cellular proliferation or cell toxicity is likely to be
due to a number of intracellular signalling mechanisms and
this is likely to be cell dependent. This clearly requires further
investigation.
We then investigated the effect of iron loading on
E-cadherin, an adherens junction protein commonly
repressed in epithelial malignancies including those of the
colon.28 29 This protein has been reported to be repressed by
iron in a hepatocellular model system.48 In this study, we
showed that iron loading of both cell lines resulted in
decreased E-cadherin promoter activity, and mRNA and
protein expression. This inverse relationship between
E-cadherin expression and iron was also observed in stained
CRC tissue sections. Thus a possible consequence of iron
loading is increased motility, invasiveness, and ultimately
metastasis through reduced E-cadherin expression.49
Consistent with this interpretation is the finding that reduced
HEPH and FPN expression was associated with extensive
vascular invasion and metastasis, respectively. How iron
might alter E-cadherin transcriptional repression remains
unclear although a candidate molecule could be the
transcription factor Snail, a member of the Slug/Snail
superfamily. Snail has been shown to repress E-cadherin
expression through the E-box sequences in the proximal
E-cadherin promoter and has been shown to be overexpressed
in CRC.50
In summary, the human colon expresses all of the proteins
necessary to absorb inorganic iron. In colorectal carcinoma
there was overexpression of components of the iron import
machinery while components of the iron export protein
machinery were either decreased in expression or misloca-
lised, suggesting a block on iron export. The net effect of
these changes is to render the colonocytes iron rich. Despite
this increased intracellular iron, expression of molecules such
as DMT1 and TfR1 remains paradoxically high, suggesting
that there may be inadequate sensing of intracellular iron or
that there may be mechanisms modulating the expression of
these proteins other than iron.
Our data would suggest that these changes in iron
transport proteins are likely to impact on late stage disease
with little evidence of a stepwise progression through the
adenoma-carcinoma sequence. This lends support to existing
evidence that iron mediates carcinogenesis in a background
of existing genetic aberrations.6 10 12 13 However, this does not
rule out an early role for iron in CRC as there are studies
implicating iron in colonocyte proliferation and aberrant
crypt foci development.13 51 Clearly performing experiments
with primary and adenoma derived cell lines would be
informative in addressing any potential early effects of iron in
colorectal neoplasia.
The observed accumulation of iron in colonocytes could drive
cell proliferation through modulation of cell cycle proteins and
induction of reactive oxygen species culminating in DNA adduct
formation and further mutagenesis, especially on a background
of loss of DNA surveillance proteins. Moreover, as evidenced in
the current study, iron is likely to cause repression of the cell
adhesion protein E-cadherin, increasing cell motility and
invasiveness and impacting on other intracellular pathways,
including Wnt signalling.
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